**PURPOSE:** Non-syndromic sagittal and/or metopic craniosynostosis, occurring once in every 4,000 live births, accounts for half of all craniosynostosis cases. Despite success in identifying the genes underlying rare syndromic craniosynostoses, mutations in these genes are very rarely found in their non-syndromic counterparts. We considered that the often sporadic occurrence of non-syndromic craniosynostosis might frequently be attributable to de novo mutation or incomplete penetrance of rare transmitted variants.

**METHODS:** To identify mutations contributing to common non-syndromic midline (sagittal and metopic) craniosynostosis, we performed exome sequencing of 132 parent-offspring trios and 59 additional probands.

**RESULTS:** Thirteen probands (7%) had damaging de novo or rare transmitted mutations in *SMAD6*, an inhibitor of BMP - induced osteoblast differentiation (p\<10^--20^). *SMAD6* mutations nonetheless showed striking incomplete penetrance (\<60%). Genotypes of a common variant near *BMP2* that is strongly associated with midline craniosynostosis explained nearly all the phenotypic variation in these kindreds, with highly significant evidence of genetic interaction between these loci via both association and analysis of linkage. A de novo mutation in *SMURF1*, a *SMAD6* binding partner, was also identified.

**CONCLUSION:** This epistatic interaction of rare and common variants defines the most frequent cause of midline craniosynostosis and has implications for the genetic basis of other diseases.
